CVS Health (NYSE:CVS) Raised to “Overweight” at Barclays

Barclays upgraded shares of CVS Health (NYSE:CVS) from an equal weight rating to an overweight rating in a research note published on Thursday, MarketBeat reports. They currently have $82.00 price target on the pharmacy operator’s stock, up from their prior price target of $63.00.

Several other research analysts have also commented on CVS. Wells Fargo & Company lifted their target price on CVS Health from $60.00 to $61.00 and gave the stock an equal weight rating in a research report on Monday, August 12th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of CVS Health from $64.00 to $63.00 and set a hold rating for the company in a research note on Friday, August 9th. Evercore ISI raised their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an outperform rating in a research report on Tuesday, October 8th. Cantor Fitzgerald reaffirmed a neutral rating and set a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Royal Bank of Canada reissued an outperform rating and issued a $68.00 target price on shares of CVS Health in a report on Wednesday, September 4th. Nine investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and a consensus price target of $75.26.

CVS Health Stock Down 0.3 %

CVS stock opened at $66.63 on Thursday. The company has a market capitalization of $83.65 billion, a P/E ratio of 11.71, a PEG ratio of 0.93 and a beta of 0.54. The firm has a 50 day simple moving average of $59.12 and a 200-day simple moving average of $60.89. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. CVS Health has a twelve month low of $52.77 and a twelve month high of $83.25.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. During the same quarter in the previous year, the firm earned $2.21 EPS. The company’s revenue was up 2.6% on a year-over-year basis. On average, equities research analysts predict that CVS Health will post 6.51 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.99%. CVS Health’s dividend payout ratio is presently 46.75%.

Institutional Investors Weigh In On CVS Health

A number of institutional investors have recently added to or reduced their stakes in CVS. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health in the 4th quarter worth $32,000. Creekmur Asset Management LLC bought a new stake in CVS Health in the fourth quarter worth about $34,000. Steph & Co. lifted its holdings in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares during the last quarter. Kapitalo Investimentos Ltda acquired a new position in shares of CVS Health in the 4th quarter worth approximately $36,000. Finally, Scarborough Advisors LLC bought a new stake in shares of CVS Health in the 4th quarter worth approximately $37,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.